Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
GRIN.CN
HOLDGrown Rogue International Inc. · Healthcare · United States · $109M · Avg Vol: $10K/d
39
StockRankGet insider-trade alerts
Q
50
V
22
M
60
P/E (TTM)
60.0x
ROE
1.3%
D/E
1.2x
Dividend %
—
COMPANY DESCRIPTION
Grown Rogue International Inc., through its subsidiaries, engages in cultivation, manufacture, possession, sale, and distribution of marijuana in the United States. It offers flower and flower pre-rolls, as well as flower-based products.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 17.8M | 23.4M | 26.6M | 32.4M | 22.2% | 34.4M |
| EPS | 0.00 | 0.00 | -0.05 | 0.01 | 55.8% | 0.01 |
| Shares | 170.6M | 182.0M | 222.4M | 249.7M | +46.4% | 249.9M |
| Debt | 4.9M | 6.7M | 10.7M | 26.7M | 75.8% | 27.5M |
| Equity | 6.9M | 11.6M | 8.9M | 20.9M | 44.5% | — |
| Op CF | 2.0M | 5.7M | 2.6M | 3.6M | 21.2% | 7.1M |
| Inv CF | -1.1M | -2.9M | -9.0M | -6.9M | — | — |
| Fin CF | -0.4M | 4.4M | 4.5M | 9.8M | — | — |
Loading 1Y...
PRICE (1Y)-8.3%
SMA 50SMA 200
Close
$0.407
RSI (14)
26.1
52W High
$0.5328
From 52W High
0.8%
SCORE BREAKDOWN
Quality
50
ROIC
10.9%76.6
ROE
1.3%48.4
GP/Assets
23.0%53.9
Op. Margin
1.1%47.7
FCF/Assets
-1.7%41.6
Piotroski
550.0
Int. Cover
4.5x50.7
D/E Ratio
1.18x11.8
Current Ratio
2.99x53.7
Value
22
P/E (TTM)
60.0x16.6
EV/EBITDA
132.6x3.3
P/FCF
—N/A
P/B
4.5x30.3
P/S
3.1x55.7
Div Yield
—N/A
Momentum
60
52W High %
76%65.2
RS 6M
-10%61.9
SMA 50/200
1.14x85.1
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$109M
P/E (Forward)
—
Gross Margin
41.9%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of GRIN.CN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| GRIN.CN | Grown Rogue International Inc.(you) | $109M | 39 | HOLD |
| JUSH.CN | Jushi Holdings Inc. | $83M | 31 | SELL |
| SCYX | SCYNEXIS, Inc. | $58M | 33 | SELL |
| TKNO | Alpha Teknova, Inc. | $266M | 37 | HOLD |
| ORGO | Organogenesis Holdings Inc. | $308M | 38 | HOLD |
| DERM | Journey Medical Corporation | $170M | 24 | SELL |
| TLPH | Talphera, Inc. | $70M | 22 | SELL |
| EOLS | Evolus, Inc. | $394M | 38 | HOLD |
| CPIX | Cumberland Pharmaceuticals Inc. | $99M | 65 | BUY |
| AKBA | Akebia Therapeutics, Inc. | $327M | 30 | SELL |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.7%